Skip to main content
Indoco Remedies Ltd. logo

Indoco Remedies Ltd. — Investor Relations & Filings

Ticker · INDOCO ISIN · INE873D01024 LEI · 3358007XE9RRPHJA6U47 BSE.NS Manufacturing
Open in API
Filings indexed 774 across all filing types
Latest filing 2021-08-27 Regulatory Filings
Country IN India
Listing BSE.NS INDOCO

About Indoco Remedies Ltd.

https://www.indoco.com/

Indoco Remedies Ltd. is a fully integrated pharmaceutical company engaged in the research, development, manufacturing, and marketing of finished dosages and Active Pharmaceutical Ingredients (APIs). The company operates multiple manufacturing facilities equipped to produce various dosage forms, including tablets, capsules, injectables, ophthalmics, and topical preparations. Its therapeutic portfolio spans stomatologicals, anti-infectives, respiratory, cardiovascular, anti-diabetics, and pain management. Indoco maintains a significant global footprint, exporting products to over 55 countries, including highly regulated markets such as the United States and Europe. The organization is recognized for its strong research and development capabilities, focusing on complex generics and niche formulations. Key brands include Sensodent-K, Febrex Plus, and Cyclopam, reflecting its leadership in specific therapeutic segments.

Recent filings

Filing Released Lang Actions
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Indoco Remedies Limited's Clinical Research Organization, AnaCipher, has received accreditation from the UK-MHRA. It is addressed to stock exchanges under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is a corporate announcement about accreditation and does not contain financial statements, management discussion, or detailed financial data. The document length is 3926 characters, which is relatively short and consistent with a press release or regulatory announcement rather than a full report. There is no indication that this is an annual report, earnings release, or any other detailed financial filing. Therefore, the document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-08-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) informing them about the schedule of upcoming analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is a notification about planned investor meetings, not a financial report, earnings release, or any detailed presentation. The document length is short (1924 characters) and it serves as an announcement of scheduled meetings rather than the meetings' content or transcript. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-08-21 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated August 20, 2021, addressed to stock exchanges (BSE and NSE) regarding the schedule of upcoming analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is purely informational about meeting dates and types, with no financial data, report content, or detailed analysis. The document length is only 1324 characters, indicating it is a brief announcement rather than a full report. It does not contain financial statements or detailed management discussion. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and disclosures that do not fit other specific categories.
2021-08-20 English
Copy of Newspaper Publication
Regulatory Filings
2021-08-12 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the audio recording of a conference call held on August 11, 2021, to discuss Q1 FY22 results and future outlook. It mentions that the audio recording link has been uploaded and that a written transcript will be submitted later. The document itself is not the transcript but an announcement about the availability of the audio recording and the forthcoming transcript. The document length is short (1241 characters), and it serves as a notification rather than containing the actual transcript or financial data. Therefore, it should be classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about the conference call recording and transcript submission, not the transcript itself or a financial report.
2021-08-11 English
Financial Result Updates
Interim / Quarterly Report Classification · 100% confidence The document is a detailed financial report containing unaudited standalone and consolidated financial results for the quarter ended June 30, 2021. It includes comprehensive financial data such as income from operations, expenses, profit before tax, tax expenses, earnings per share, and segment information. The report also contains a limited review certificate from statutory auditors, which is typical for interim or quarterly financial reports. The presence of detailed financial statements and analysis for a quarter, along with auditor review, aligns with the characteristics of an Interim / Quarterly Report (IR). The document is lengthy (15,000 characters) and contains substantive financial data, not merely an announcement or certification, so it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS). Therefore, the correct classification is Interim / Quarterly Report (IR). Q1 2022
2021-08-11 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.